[Skip to Navigation]
Views 2,274
Citations 0
JAMA Network Insights
November 11, 2020

Five Things to Know When a Psychiatric Patient Is Prescribed Opioids for Pain

Author Affiliations
  • 1Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland
JAMA Psychiatry. 2021;78(2):220-221. doi:10.1001/jamapsychiatry.2020.3547

Opioids are commonly prescribed for chronic pain. In the United States, opioid prescribing increased 4-fold in the early 2000s, accompanied by increases in opioid-related overdose and addiction. Therefore, policy efforts have focused on reducing inappropriate or unnecessary opioid prescribing. Nonetheless, opioids remain a management option for chronic pain in selected patients. Because the prevalence of psychiatric conditions is high in those with chronic pain, psychiatrists often encounter patients prescribed opioids and can play an essential role in management. This article summarizes 5 key things for psychiatrists to know in this situation.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    EXPAND ALL
    Avoiding stigma
    Robert Kerns, PhD | Yale University
    Dr. Chou and others publishing in JAMA should strive to avoid use of stigmatizing terms such as "psychiatric patient." Furthermore, although it may be understandable that authors publishing in JAMA may be primarily physician readers, in this and many other cases, it is disappointing and potentially limiting to call out "psychiatrists" versus the much broader array of healthcare professionals who provide care for persons with mental health problems. In this case, it is noteworthy that the nonpharmacological and noninvasive approaches cited as alternatives to medications have largely been developed and empirically evaluated by teams led by psychologists, not psychiatrists, and other non-physicians. Use of terms and labels that are more inclusive and reflective of a diverse practice community is preferable.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    ×